Log in
Enquire now
Engitix

Engitix

Human extracellular matrix (ECM)-based discovery platform for the treatment of fibrosis and cancer

OverviewStructured DataIssuesContributors

Contents

engitix.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biomedical engineering
Biomedical engineering
Drug discovery
Drug discovery
Biotechnology
Biotechnology
Engineering
Engineering
Location
United Kingdom
United Kingdom
B2X
B2B
B2B
0
CEO
Giuseppe Mazza
Giuseppe Mazza
Founder
Giuseppe Mazza
Giuseppe Mazza
‌
Massimo Pinzani
Pitchbook URL
pitchbook.com/profiles...234813-79
Legal Name
Engitix Limited
Legal classification
Private limited company
Private limited company
Date Incorporated
July 21, 2016
Spun Out From
UCL Business Ltd
UCL Business Ltd
Number of Employees (Ranges)
51 – 2000
Email Address
info@engitix.com
Number of Employees
540
Full Address
21 Lombard Street, London, United Kingdom, EC3V 9AH
Incorporation Reference
10290441
Investors
‌
Netherton Investments
Founded Date
2016
0
Total Funding Amount (USD)
85,400,000
Latest Funding Round Date
January 8, 2026
Latest Funding Type
Series A
Series A
Country
United Kingdom
United Kingdom
Headquarters
London
London

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
25,000,000
UKSIC Code
72110
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Engitix

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.